1Tutor, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
2Senior Lecturer, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
3Senior Lecturer, Department of Public Health Dentistry, Institute of Dental Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
4Senior Lecturer, Department of Public Health Dentistry, Santosh Dental College, Ghaziabad, Uttar Pradesh, India
Biomarkers are frequently used for understanding the physiological processes which are changing with age or any disease which developed and closely related to age also to aging process itself. Some of the best examples’ biomarkers are pathological analysis, imaging pattern lipids and protein. The biomarkers are created in our body by response to any systemic disease or by any tumour biomarkers are very useful in spectrum of disease progression. During the time of diagnosis, biomarkers can determine staging, grading, and selection of initial therapy. During treatment, they can be used tomonitor therapy, select additional therapy, or monitor recurrent diseases. Recent advances in, proteomics and molecular pathology have created lots of candidate biomarkers with highly potential clinical value. In the near future, introduction of biomarkers, identified using new advanced technologies, into medical practice will be necessary to achieve “personalization” of treatment and disease prevention.
Biomarkers, Evaluation of biomarker
